“We are delighted with this agreement. With Valeant/Medicis expertise and strength in the medical aesthetics market, our line GliSODin Skin Nutrients will be able to reach its full potential in Canada,” says François Vix, ISOCELL CEO.
Many of North America’s leading Surgeons and Dermatologists have put their names behind the non-topical skincare line. For years doctors have been looking for the ultimate product that provides the natural glow that seems to be lost as one ages. The restoration of our aging cells naturally is not a new idea, but one that is now being put into practice by nutraceutical brands like GSN.
“We believe GSN aligns well with Valeant’s diverse aesthetic portfolio. We are thrilled to have Valeant behind GSN to expand our distribution within Canada, and showcase the efficacy of our products,” says Corina Crysler, Executive Director and Formulator of GSN.
About Valeant Canada
Valeant Canada is a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.
More information about Valeant Canada can be found at www.valeantcanada.com.
Founded in 2001 by François Vix, a former brand manager and senior executive for L’Oreal, Lancôme, Neutrogena International and Johnson & Johnson, ISOCELL is a Paris-based biotech company with its origins in immunotherapy. ISOCELL is one of the leading French laboratories in aging research, particularly in the domain of oxidative stress. The company owns five international patent families for research on aging. ISOCELL exclusively features the bio-nutrient GliSODin®, a patented form of Superoxide Dismutase (SOD) that is ingested orally. In 2008, ISOCELL North America, led by Corina Crysler, launched GliSODin Skin Nutrients. www.glisodinskin.com.
Executive Director & Formulator
T. 416-850-2509 | e. firstname.lastname@example.org